CARLI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 14.579
EU - Europa 6.622
AS - Asia 5.888
SA - Sud America 743
Continente sconosciuto - Info sul continente non disponibili 228
AF - Africa 165
OC - Oceania 17
Totale 28.242
Nazione #
US - Stati Uniti d'America 14.205
GB - Regno Unito 2.804
SG - Singapore 1.844
CN - Cina 1.460
IT - Italia 1.029
HK - Hong Kong 662
VN - Vietnam 623
SE - Svezia 595
BR - Brasile 552
DE - Germania 544
FI - Finlandia 336
BD - Bangladesh 301
FR - Francia 288
RU - Federazione Russa 268
UA - Ucraina 247
TR - Turchia 238
CA - Canada 237
IN - India 174
KR - Corea 135
BG - Bulgaria 103
ID - Indonesia 90
MX - Messico 71
ZA - Sudafrica 64
AR - Argentina 55
IQ - Iraq 55
NL - Olanda 52
ES - Italia 51
PL - Polonia 44
JP - Giappone 39
SI - Slovenia 36
CO - Colombia 30
LT - Lituania 30
IR - Iran 29
EC - Ecuador 28
AE - Emirati Arabi Uniti 25
PK - Pakistan 25
MY - Malesia 24
CL - Cile 23
PH - Filippine 23
BE - Belgio 21
IE - Irlanda 21
MA - Marocco 21
IL - Israele 18
RO - Romania 18
CZ - Repubblica Ceca 17
SA - Arabia Saudita 17
VE - Venezuela 16
AT - Austria 15
PE - Perù 15
TH - Thailandia 15
UZ - Uzbekistan 15
AU - Australia 14
EU - Europa 14
NG - Nigeria 13
GR - Grecia 12
JM - Giamaica 12
CH - Svizzera 11
CR - Costa Rica 11
NP - Nepal 11
EG - Egitto 10
ET - Etiopia 10
JO - Giordania 10
PY - Paraguay 10
AL - Albania 9
DZ - Algeria 9
SN - Senegal 9
MD - Moldavia 8
SK - Slovacchia (Repubblica Slovacca) 8
BO - Bolivia 7
DK - Danimarca 7
KE - Kenya 7
NO - Norvegia 7
UY - Uruguay 7
AZ - Azerbaigian 6
BA - Bosnia-Erzegovina 6
BY - Bielorussia 6
DO - Repubblica Dominicana 6
NI - Nicaragua 6
PT - Portogallo 6
TW - Taiwan 6
CI - Costa d'Avorio 5
HU - Ungheria 5
KZ - Kazakistan 5
PA - Panama 5
QA - Qatar 5
SV - El Salvador 5
EE - Estonia 4
LB - Libano 4
LV - Lettonia 4
PR - Porto Rico 4
RS - Serbia 4
HN - Honduras 3
HR - Croazia 3
KH - Cambogia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
OM - Oman 3
PS - Palestinian Territory 3
SD - Sudan 3
SY - Repubblica araba siriana 3
Totale 27.983
Città #
Southend 2.319
Ashburn 1.409
Santa Clara 1.289
Singapore 1.202
Fairfield 1.149
Woodbridge 790
Chandler 787
Hong Kong 646
San Jose 594
Houston 566
Seattle 440
Jacksonville 436
Wilmington 412
Cambridge 371
Dearborn 357
Dallas 350
Beijing 349
Nyköping 346
Council Bluffs 344
Ann Arbor 307
Hefei 298
London 252
Los Angeles 248
Chicago 239
Modena 224
Helsinki 214
Ho Chi Minh City 202
New York 202
The Dalles 181
Seoul 133
Hanoi 131
Izmir 130
Munich 121
Princeton 114
Milan 104
San Diego 100
Sofia 100
Shanghai 95
Lauterbourg 90
Salt Lake City 90
Eugene 84
Buffalo 79
Bremen 66
Moscow 63
Toronto 62
Jakarta 55
Columbus 54
Frankfurt am Main 53
Tampa 52
Redwood City 50
Johannesburg 45
Turku 45
São Paulo 44
Elk Grove Village 43
Atlanta 41
Montreal 41
Phoenix 41
Boardman 40
North York 37
Orem 35
Warsaw 35
Bologna 34
Chennai 33
Falls Church 33
Brooklyn 30
Mexico City 30
Tokyo 30
Da Nang 29
Rome 29
Fremont 28
Baghdad 27
Mumbai 27
Guangzhou 26
Sterling 26
Amsterdam 25
Dong Ket 23
Haiphong 23
Parma 23
Denver 21
Dublin 21
Des Moines 20
San Francisco 20
Detroit 19
Stockholm 19
Brussels 18
Dhaka 18
Miami 18
Nanjing 18
Norwalk 18
Paris 18
Dongguan 17
Lancaster 17
Naples 16
Secaucus 16
Poplar 15
Tashkent 15
Beauharnois 14
Bengaluru 14
Dulles 14
Madrid 14
Totale 19.652
Nome #
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: An Italian cost impact study 810
Hypertriglyceridemia and Waist Circumference Predict Cardiovascular Risk among HIV Patients: A Cross-Sectional Study 745
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 523
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 491
Human immunodeficiency virus infection is associated with accelerated atherosclerosis. 474
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 469
Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV 448
Premature age-related comorbidities among HIV-infected persons compared with the general population 438
GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls 414
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 400
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 381
Inverse correlation between vascular calcification and bone mineral density in human immunodeficiency virus-infected patients 379
Erectile Dysfunction Is Not a Mirror of Endothelial Dysfunction in HIV-Infected Patients. 378
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 378
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 375
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 367
Ectopic fat is linked to prior cardiovascular events in men with HIV. 352
Cost of noninfectious comorbidities in patients with HIV 349
Changes in central adipose tissue after switching to integrase inhibitors 340
Hypokalemia in Patients with COVID-19 337
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 332
Thymus Imaging Detection and Size Is Inversely Associated With Metabolic Syndrome and Frailty in People With HIV 330
Serum sodium is inversely related to frailty and bone mineral density (BMD) in human immunodeficiency virus (HIV)-infected patients 329
Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. 326
Progression of coronary artery calcium in men affected by human immunodeficiency virus infection. 326
Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients 324
Abstract: P784 ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 322
Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study 318
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women 317
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 314
Peritoneal dialysis in the time of coronavirus disease 2019 308
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 306
HIV patients undergoing second generation antipsychotics show high cardiovascular disease burden 305
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 300
Body Composition changes in ageing HIV infected patients: the complex interplay between low muscle mass, lipodystrophy and osteopenia. 299
Combined Use of Waist and Hip Circumference to Identify Abdominally Obese HIV-Infected Patients at Increased Health Risk 298
Surgical correction of HIV-associated facial lipoatrophy. 293
Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. 293
A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living with HIV 289
Premature Decline of Serum Total Testosterone in HIV-Infected Men in the HAART-Era 289
Acute myocarditis as the main clinical manifestation of SARS-CoV 2 infection: A case report 288
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: Monarch randomized controlled trial 287
Associatioin of epicardial adipose tissue with incident coronary heart disease and death in HIV infected patients. 285
A randomized, controlled trial to evaluate change in cardiometabolic and endothelial function in HIV-infected patients with optimal viral suppression on Darunavir/ritonavir monotherapy vs. triple-therapy. 281
Prediction of hard cardiovascular events in HIV patients 280
American College of Cardiology pooled equations and DAD algorithm to predict freedom from cardiovascular events in HIV patients 279
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women. 279
The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV 273
Changes with menopause in the distribution of frailty index (FI) in HIV infected women. 269
Antiretroviral drugs induced metabolic diseases in HIV infected patients. 268
Combined use of waist and thigh circumference to identify high-risk,, abdominally obese HIV+ patients. 264
CD4 nadir and antiretroviral exposure predict premature polypathology onset 259
Should we screen for NAFLD/NASH in HIV patients? 258
ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 258
Cost of non-infectious co-morbidities in patients with HIV 254
Abacavir and Tenofovir impact on endothelial. 254
Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons 254
Coronary artery calcification is associated with femoral but not with lumbar spine mineral density 252
Assessment of 10-year probability of a major osteoporotic fracture in HIV-infected patients using FRAX® tool algorithms. 248
Vitamin D3 supplementation decreases the risk of diabetes mellitus among patients with HIV infection. 246
Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside Analogues 236
Coronary aging in HIV-infected patients 229
Emphysema is an independent predictor of coronary artery calcium score in a large cohort of HIV infected patients 229
Sex Differences in People Aging With HIV 228
Emphysema is an independent predictor of coronary artery calcium score in a large cohort of HIV-infected patients. 223
Sensitivity and specificity of visceral and epicardial adipose tissue values in the prediction of occult cardiovascular disease in HIV-infected patients. 221
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years 221
Health status is related to testosterone, estrone and body fat: moving to functional hypogonadism in adult men with HIV. 218
Two methods of measuring frailty among people aging with HIV 216
Relationship between weight gain and insulin resistance in people living with HIV switching to INSTI-based regimens 216
CORONARY AGEING IN HIV INFECTED PATIENTS 215
Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study. 215
Determinants of erectile dysfunction changes in HIV infected men: a prospective study. 214
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 214
Coronary artery calcification is associated with femoral but not with lumbar spine mineral density 212
How do frailty mediate pathway leading to disability 206
EAT volume is an independent risk factor of cardiovascular disease in HIV-infected patients 205
Vitamin D3 Supplementation Decreases the Risk of Diabetes Mellitus among Patients with HIV Infection 191
Visceral fat but not general adiposity is a predictor of sub-clinical atherosclerosis in HIV-infected patients with lipodystrophy. 190
Erectile dysfunction does not mirror sub-clinical atherosclerosis in HIV infected males. 189
Premature decline of serum total testosterone in human immunodeficiency virus (HIV) infected men with HIV-related lipodystrophy in the highly active antiretroviral therapy (HAART) era: a cross-sectional observational study 188
Menopause In Hiv Infected Patients: Women In A Midlife Polypathology Crisis 184
Impact of prolonged maraviroc treatment on non-AIDS-related comorbidities in HIV-positive patients: a retrospective cohort study 183
Ectopic fat is a surrogate marker of CVD in patients with HIV. 178
Tenofovir accelerates bone mass loss of the lumbar spine in the first year of menopause in HIV infected women. 176
Lipodistrophy and ectopic adipose tissue are associated with activated immune phenotype in HIV-infected patients on virologically suppressive ART. 174
Clinical evaluation is better than risk prediction algorithms to identify patients who need statin therapy. 173
Erratum to: Ageing with HIV: a multidisciplinary review(Infection, Doi:10.1007/s15010-015-0795-5) 172
Vascular age as a marker of premature biological ageing in HIV-infected patients 169
Renal hyperfiltration and outcome in HIV-infected subjects. 169
Costs of Non-Infectious co-morbidities in patients with HIV. 167
Serum Sodium Is Inversely Related to Frailty and Bone Mineral Density (BMD) in Human Immunodeficiency Virus (HIV)-Infected Patients 164
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 164
Epicardial Adipose Tissue Volume is an Independent Risk Factor of CVD in HIV-infected Patients 162
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-infected Patient 161
Moving from risk factor assessment to atherosclerosis imaging to select the most appropriate patient for primary prevention 158
Coronary ageing in hiv-infected patients 155
Low Muscle Mass in HIV+ Patients: Prevalence, Predictors, and Clinical Implication. 154
Erratum: Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection (AIDS (2011) 25 (707-711)) 150
Progression of subclinical atherosclerosis in HIV-infected patients 150
Totale 28.041
Categoria #
all - tutte 104.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.715 0 0 157 160 75 139 133 103 202 167 306 273
2022/20232.190 241 265 222 220 252 301 46 212 256 24 64 87
2023/20241.405 36 85 96 131 263 214 96 153 30 47 85 169
2024/20254.275 130 84 74 302 877 639 319 207 529 194 368 552
2025/20268.482 470 294 749 1.006 1.668 520 996 360 767 736 507 409
2026/20271.002 291 671 40 0 0 0 0 0 0 0 0 0
Totale 28.242